A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)

Middleton, Gary; Brown, Sarah; Lowe, Catherine; Maughan, Timothy; Gwyther, Stephen; Oliver, Alfred; Richman, Susan; Blake, Denise; Napp, Vicky; Marshall, Helen; Wadsley, Jonathan; Maisey, Nick; Chau, Ian; Hill, Mark; Gollins, Simon; Myint, Sun; Slater, Sarah; Wagstaff, John; Bridgewater, John; Seymour, Matthew

doi:10.1016/j.ejca.2013.06.017

Journal article 996 views

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO...

Gary Middleton, Sarah Brown, Catherine Lowe, Timothy Maughan, Stephen Gwyther, Alfred Oliver, Susan Richman, Denise Blake, Vicky Napp, Helen Marshall, Jonathan Wadsley, Nick Maisey, Ian Chau, Mark Hill, Simon Gollins, Sun Myint, Sarah Slater, John Wagstaff, John Bridgewater, Matthew Seymour

European Journal of Cancer, Volume: 49, Issue: 16, Pages: 3507 - 3516

Swansea University Author: John Wagstaff

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1016/j.ejca.2013.06.017

Published in:	European Journal of Cancer
ISSN:	0959-8049
Published:	2013
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa16200

first_indexed	2013-09-26T11:46:18Z
last_indexed	2018-02-09T04:48:45Z
id	cronfa16200
recordtype	SURis
fullrecord	<?xml version="1.0"?><rfc1807><datestamp>2016-04-21T12:53:03.4385130</datestamp><bib-version>v2</bib-version><id>16200</id><entry>2013-09-23</entry><title>A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)</title><swanseaauthors><author><sid>fdab5e9e2fe06c93d3ffa19c816bdcf6</sid><firstname>John</firstname><surname>Wagstaff</surname><name>John Wagstaff</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2013-09-23</date><deptcode>MEDS</deptcode><abstract></abstract><type>Journal Article</type><journal>European Journal of Cancer</journal><volume>49</volume><journalNumber>16</journalNumber><paginationStart>3507</paginationStart><paginationEnd>3516</paginationEnd><publisher/><issnPrint>0959-8049</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2013</publishedYear><publishedDate>2013-12-31</publishedDate><doi>10.1016/j.ejca.2013.06.017</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-04-21T12:53:03.4385130</lastEdited><Created>2013-09-23T10:16:46.0912899</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Gary</firstname><surname>Middleton</surname><order>1</order></author><author><firstname>Sarah</firstname><surname>Brown</surname><order>2</order></author><author><firstname>Catherine</firstname><surname>Lowe</surname><order>3</order></author><author><firstname>Timothy</firstname><surname>Maughan</surname><order>4</order></author><author><firstname>Stephen</firstname><surname>Gwyther</surname><order>5</order></author><author><firstname>Alfred</firstname><surname>Oliver</surname><order>6</order></author><author><firstname>Susan</firstname><surname>Richman</surname><order>7</order></author><author><firstname>Denise</firstname><surname>Blake</surname><order>8</order></author><author><firstname>Vicky</firstname><surname>Napp</surname><order>9</order></author><author><firstname>Helen</firstname><surname>Marshall</surname><order>10</order></author><author><firstname>Jonathan</firstname><surname>Wadsley</surname><order>11</order></author><author><firstname>Nick</firstname><surname>Maisey</surname><order>12</order></author><author><firstname>Ian</firstname><surname>Chau</surname><order>13</order></author><author><firstname>Mark</firstname><surname>Hill</surname><order>14</order></author><author><firstname>Simon</firstname><surname>Gollins</surname><order>15</order></author><author><firstname>Sun</firstname><surname>Myint</surname><order>16</order></author><author><firstname>Sarah</firstname><surname>Slater</surname><order>17</order></author><author><firstname>John</firstname><surname>Wagstaff</surname><order>18</order></author><author><firstname>John</firstname><surname>Bridgewater</surname><order>19</order></author><author><firstname>Matthew</firstname><surname>Seymour</surname><order>20</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling	2016-04-21T12:53:03.4385130 v2 16200 2013-09-23 A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO) fdab5e9e2fe06c93d3ffa19c816bdcf6 John Wagstaff John Wagstaff true false 2013-09-23 MEDS Journal Article European Journal of Cancer 49 16 3507 3516 0959-8049 31 12 2013 2013-12-31 10.1016/j.ejca.2013.06.017 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2016-04-21T12:53:03.4385130 2013-09-23T10:16:46.0912899 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Gary Middleton 1 Sarah Brown 2 Catherine Lowe 3 Timothy Maughan 4 Stephen Gwyther 5 Alfred Oliver 6 Susan Richman 7 Denise Blake 8 Vicky Napp 9 Helen Marshall 10 Jonathan Wadsley 11 Nick Maisey 12 Ian Chau 13 Mark Hill 14 Simon Gollins 15 Sun Myint 16 Sarah Slater 17 John Wagstaff 18 John Bridgewater 19 Matthew Seymour 20
title	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
spellingShingle	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO) John Wagstaff
title_short	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
title_full	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
title_fullStr	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
title_full_unstemmed	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
title_sort	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
author_id_str_mv	fdab5e9e2fe06c93d3ffa19c816bdcf6
author_id_fullname_str_mv	fdab5e9e2fe06c93d3ffa19c816bdcf6_***_John Wagstaff
author	John Wagstaff
author2	Gary Middleton Sarah Brown Catherine Lowe Timothy Maughan Stephen Gwyther Alfred Oliver Susan Richman Denise Blake Vicky Napp Helen Marshall Jonathan Wadsley Nick Maisey Ian Chau Mark Hill Simon Gollins Sun Myint Sarah Slater John Wagstaff John Bridgewater Matthew Seymour
format	Journal article
container_title	European Journal of Cancer
container_volume	49
container_issue	16
container_start_page	3507
publishDate	2013
institution	Swansea University
issn	0959-8049
doi_str_mv	10.1016/j.ejca.2013.06.017
college_str	Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id	facultyofmedicinehealthandlifesciences
hierarchy_top_title	Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id	facultyofmedicinehealthandlifesciences
hierarchy_parent_title	Faculty of Medicine, Health and Life Sciences
department_str	Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str	0
active_str	0
published_date	2013-12-31T18:29:58Z
_version_	1821340648928706560
score	11.1586075

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO...

Similar Items